Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

• Status: Completed
• Trial end date: 2019-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is a single-center prospective study evaluating the diagnostic performance and safety of Infracyanine in women with early breast cancer whose the research of sentinel node(s) combines isotopes and Infracyanine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Criteria

Inclusion Criteria:

1. Female age > 18 years

2. Invasive breast cancer ≤ 5 cm, unifocal bifocal or multifocal

3. Diagnosis confirmed by biopsy

4. Breast cancer extended in situ

5. First surgical treatment

Exclusion Criteria:

1. Neoadjuvant chemotherapy or hormone therapy.

2. Multicentric tumor

3. Pregnant patient

4. Ongoing participation in another clinical trial with an investigational drug